PANews reported on December 17th that, according to PR Newswire, the board of directors of Canaan Inc. (NASDAQ: CAN) has authorized a repurchase of up to $30 millionPANews reported on December 17th that, according to PR Newswire, the board of directors of Canaan Inc. (NASDAQ: CAN) has authorized a repurchase of up to $30 million

Canaan Technology announced an extension of its $30 million share buyback program, extending it to 12 months.

2025/12/17 22:21

PANews reported on December 17th that, according to PR Newswire, the board of directors of Canaan Inc. (NASDAQ: CAN) has authorized a repurchase of up to $30 million worth of ADS or Class A ordinary shares over the next 12 months, funded by existing cash. The company stated that it will conduct the repurchase through open market, private placement, or block trades, complying with the Securities Exchange Act of 1934 and its insider trading policy. The pace of the repurchase will depend on price, trading volume, and market conditions. The previous six-month repurchase program, which began on May 27th, has expired, with a cumulative repurchase of 6.5864 million ADSs, totaling approximately $4.9 million, including 1.5053 million ADSs, worth approximately $1.5 million, repurchased between November 19th and 27th. The company may adjust the size and terms of the program as needed.

Market Opportunity
WorldAssets Logo
WorldAssets Price(INC)
$0.5886
$0.5886$0.5886
+1.78%
USD
WorldAssets (INC) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.